AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) bought $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Aug 5, 2019.
The trade happened on Jul 15, 2019, 21 days before it was made public.
BMY has moved +38.4% since the trade date, from $44.19 to $61.15 (Oct 2, 2026 close).
- Traded
- Jul 15, 2019
- Disclosed
- Aug 5, 2019
- Filing delay
- 21 days
- Price since
- +38.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (35)
- SellABBV$15K-$50KAug 5, 2019
- SellBWXT$15K-$50KAug 5, 2019
- BuyDOW$15K-$50KAug 5, 2019
- BuyDOW$15K-$50KAug 5, 2019
- BuyKR$15K-$50KAug 5, 2019
- SellBWXT$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellDD$1K-$15KAug 5, 2019
- SellDD$1K-$15KAug 5, 2019
- BuyENTG$1K-$15KAug 5, 2019
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.